Imminently sub-10c?, page-42

At the most basic level the white paper will provide "empirical" evidence that the product is helping special needs kids. Up to this point, all the evidence is "anecdotal", that is- if you walk into a school you can only say things like "we think our product helps special needs kids" or "you will observe special needs children responding favourably to our product blah blah".

What's missing is the ability to say things like "if your students use this product it will result in X improvement in Y timeframe", i.e. actual data related to the benefits. It's only once we have this data will education boards (at the federal level) take us seriously.

We met with the US Board of Education in December and this was re-iterated by them. We need to have academic studies to quantify the benefit. Then these results can be equated into dollars and cents. If the US Board of Education can sit down and calculated that an allocation of funds set aside for special needs programs will result in cost savings of X% with increased productivity of Y% and increased rates of engagement and attention of Z% then we're talking their language.

The white paper (hopefully more than one) will be important when we look to rollout on national scales (US, Australia, Singapore, Phillipines etc).

Does that help?